Strata Critical Medical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Strata Critical Medical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-1.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 60% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$134Sales grew 35% in 3 years; of every extra $100 of sales, $134 became extra profit.
Higher than 84% of Healthcare companies in United States.
Asset Productivity Ratio
+35% / +0%In 3 years sales changed by +35% while total assets changed by +0%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-75.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 79% of Healthcare companies in United States.
Cash Cushion Ratio
+14%Cash, after subtracting all debt, equals 14% of its market value (net cash).
Higher than 56% of Healthcare companies in United States.
Tangible Assets Ratio
58%Of every $100 the company owns, $58 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 70% of Healthcare companies in United States.
Tangible Net Worth Ratio
51%Of every $100 of net worth, $51 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 52% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Strata Critical Medical, Inc. made a loss over the last year. Strata Critical Medical, Inc. owes $0.16 for every $1 it owns. Strata Critical Medical, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossStrata Critical Medical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.48The share price is 1.48 times Strata Critical Medical, Inc.'s book value per share, lower than 68% of Healthcare companies in United States.
Market cap
$412 MThe total market value of all of Strata Critical Medical, Inc.'s shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$279 MWhat Strata Critical Medical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.16Net worth divided by the number of shares. The share price of $4.66 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
-9.2%Strata Critical Medical, Inc. lost 9.2% of its shareholders' money over the last year, higher than 72% of Healthcare companies in United States.
Owes vs Owns
0.16×Strata Critical Medical, Inc. owes $0.16 for every $1 it owns (low), lower than 79% of Healthcare companies in United States.
Dividend yield
NoneStrata Critical Medical, Inc. does not currently pay a dividend.
Revenue growth
+34%Revenue rose 34% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Profit growth
Back to profitStrata Critical Medical, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
21.0%Strata Critical Medical, Inc. keeps $21 of every $100 of revenue as net profit.
Cash quality
-1.2×Cash from Strata Critical Medical, Inc.'s business was -1.2× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.
Cash vs debt
Net cashStrata Critical Medical, Inc. held $58 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Strata Critical Medical, Inc.: $412 M ÷ $279 M (30 Jun 2026) = 1.5.
What is Strata Critical Medical, Inc.'s return on equity?
Strata Critical Medical, Inc. lost 9.2% of its shareholders' money over the last year, higher than 72% of Healthcare companies in United States.
How much does Strata Critical Medical, Inc. owe compared with what it owns?
Strata Critical Medical, Inc. owes $0.16 for every $1 it owns (low), lower than 79% of Healthcare companies in United States.
Does Strata Critical Medical, Inc. pay a dividend?
No. Strata Critical Medical, Inc. does not currently pay a dividend.
Is Strata Critical Medical, Inc.'s revenue growing?
Revenue rose 34% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.